daGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Status
- RECRUITING
- Phase
- PHASE3
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )
- Status
- RECRUITING
- Phase
- PHASE2
Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Amping up With PemJAK
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
- Status
- RECRUITING
- Phase
- PHASE2
Retifanlimab and Ruxolitinib In Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2